Atlas Trials

Option B+: Study on Safety, Viral Suppression, and Survival on Second Line ART

Clinical trial NCT02249962 · COMPLETED

Trial details

NCT number
NCT02249962
Sponsor
University of North Carolina, Chapel Hill
Status
COMPLETED
Study type
OBSERVATIONAL
HIVInfant Exposure to Efavirenz
Start date
2015-05-01
Primary completion
2020-09-01
Enrollment
12011

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.